Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens-Reference-Cited by-同舟云学术

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens

Published:2009-04-12 Issue:5 Volume:15 Page:566-571
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Fan Alice C,Deb-Basu Debabrita,Orban Mathias W,Gotlib Jason R,Natkunam Yasodha,O'Neill Roger,Padua Rose-Ann,Xu Liwen,Taketa Daryl,Shirer Amy E,Beer Shelly,Yee Ada X,Voehringer David W,Felsher Dean W

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.1903.pdf

Reference40 articles.

1. Futreal, P.A. et al. Cancer and genomics. Nature 409, 850–852 (2001).

2. Harris, H. Tumour suppression: putting on the brakes. Nature 427, 201 (2004).

3. Sharpless, N.E. & DePinho, R.A. Cancer: crime and punishment. Nature 436, 636–637 (2005).

4. Vogelstein, B. & Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 10, 789–799 (2004).

5. Dalla-Favera, R. et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 79, 7824–7827 (1982).

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minireview on Fluid Manipulation Techniques for the Synthesis and Energy Applications of Two-Dimensional MXenes: Advances, Challenges, and Perspectives;Energy & Fuels;2023-05-08

2. The development of microfluidic-based western blotting: Technical advances and future perspectives;Journal of Chromatography A;2023-02

3. A Composition of Phytonutrients for Glycemic and Weight Management;Nutrients;2022-09-14

4. Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols;ACS Medicinal Chemistry Letters;2022-03-30

5. Bi-steric mTORC1-selective Inhibitors activate 4EBP1 reversing MYC-induced tumorigenesis and synergize with immunotherapy;2022-02-05